David M. Knott Jr’s Myriad Genetics MYGN Stock Holding History

David M. Knott Jr’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-180,000	Closed	-$956K	–	97
2025 Q2	$956K	Buy	180,000 +20,000	+13%	+$118K	0.43%	33
2025 Q1	$1.42M	Buy	+160,000	New	+$1.92M	0.67%	23

Other funds holding MYGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

David M. Knott Jr's MYGN Position: Q3 2025 in Review

David M. Knott Jr sold out of Myriad Genetics (MYGN) in Q3 2025, closing a stake of 180,000 shares — an estimated $956K sold.

David M. Knott Jr first reported a position in MYGN in Q1 2025 and held it in 2 quarters. The position peaked at $1.42M in Q1 2025. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2025.

David M. Knott Jr reported no remaining Myriad Genetics position as of Q3 2025 after selling out during the quarter.
David M. Knott Jr sold 180,000 Myriad Genetics shares in Q3 2025, an estimated $956K.
David M. Knott Jr first reported a position in Myriad Genetics in Q1 2025 and held it in 2 quarters.
David M. Knott Jr's Myriad Genetics position peaked at $1.42M in Q1 2025.
221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2025.

Based on David M. Knott Jr's 13F filing for Q3 2025, filed 12 Nov 2025.